Analyst Consensus ?
ConsensusBuy22 ratings
Bullish1881.8%
Neutral418.2%
Bearish00.0%
Axon Enterprise, Inc. · AXON · FY2024 Q3 · Calendar Q4 2024
Axon Q3: AI SaaS and TASER demand support raised outlook
The current analysis supports a constructive but conditional view: record bookings, 32% revenue growth, AI SaaS adoption, TASER 10 demand, and raised guidance strengthen the case for continued growth. The thesis still depends on converting AI adoption into profitable revenue while managing hardware capacity, Dedrone integration costs, pricing, and regulatory execution.
Reported After market closeNASDAQIndustrials
$34.09B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$1.45
Consensus $1.20
EPS surprise
+20.8%
Reported versus consensus
Reported revenue
$544.3M
Consensus $525.3M
Revenue surprise
+3.6%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
+28.7%
Event window
SPY move
+0.4%
Same window
Abnormal move
+28.2%
Stock minus SPY
Volume
8.1×
Versus trailing sessions
Subsequent drift
+6.5%
Up to 20 sessions
AXONSPY benchmark
Ask FN2 about AXON FY2024 Q3
Transcript, numbers and history already loaded
Why did AXON rise 28.7% after beating EPS estimates in FY2024 Q3?What changed in AXON's guidance and outlook in FY2024 Q3?Give me the bull and bear case for AXON after FY2024 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior analysis, the current quarter adds record bookings above $1 billion, a more explicit AI Era bundle and pricing structure, the completed Dedrone acquisition, a new real-time translation priority, and raised Q4 and FY24 guidance. International TASER expansion and software growth remain central, while integration expense and AI monetization are more immediate watch items.
Guidance delta
Management raised Q4 and FY24 guidance, forecasting more than 30% revenue growth and a 24.6% adjusted EBITDA margin.
Key takeaways
- Revenue grew 32% year over year and bookings exceeded $1 billion, the strongest quarter in company history.
- Management positioned AI Era and Draft One as core SaaS growth engines with rapid customer adoption.
- TASER 10 demand continued to support international expansion, while capacity expansion remains a focus.
- The Dedrone acquisition broadens drone-detection and counter-UAS capabilities and adds integration work.
- Pricing, AI revenue timing, hardware capacity, and Q4 integration costs remain key execution variables.
Management priorities
- Launch and expand the AI Era bundle, including new AI features such as real-time translation.
- Scale Dedrone’s sensor platform for counter-drone and Drone as First Responder use cases.
- Increase international sales of TASER 10 and related accessories.
- Continue capacity expansion for TASER and Fleet hardware.
- Invest in real-time crime-center and body-camera connectivity software.
Follow AXON with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$422.89Current
$300Low
$663.7Average
$900High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 10, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Argus Research | Buy | Buy | Maintain | Sep 3, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 6, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 6, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Aug 6, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 6, 2026 |
| Needham | Buy | Buy | Maintain | Jul 6, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jun 25, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | May 7, 2026 |
| TD Cowen | Buy | Buy | Maintain | Apr 8, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 8, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Feb 25, 2026 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Sep 29, 2025 |
| B of A Securities | Buy | Buy | Maintain | Aug 6, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Aug 5, 2025 |
| Northland Capital Markets | Outperform | Outperform | Maintain | Aug 5, 2025 |
| Craig-Hallum | Buy | Hold | Upgrade | Aug 5, 2025 |
| Citizens Capital Markets | Market Outperform | Market Outperform | Maintain | Feb 26, 2025 |
| Baird | Outperform | Outperform | Maintain | Dec 6, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | May 10, 2023 |
| Imperial Capital | In Line | In Line | Maintain | May 18, 2020 |
| Ladenburg Thalmann | Neutral | Buy | Downgrade | Oct 15, 2018 |
| CL King | Neutral | Buy | Downgrade | Mar 16, 2018 |
Named analyst price targets
Upside is calculated against the persisted current price $422.89. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Argus Research | Analyst unavailable | $600 | $506.98 | +41.9% | Sep 3, 2026 |
| Morgan Stanley | Meta Marshall | $640 | $528.41 | +51.3% | Aug 6, 2026 |
| Goldman Sachs | Analyst unavailable | $715 | $561.47 | +69.1% | Aug 6, 2026 |
| Piper Sandler | Analyst unavailable | $732 | $551.4 | +73.1% | Aug 6, 2026 |
| Barclays | Analyst unavailable | $688 | $609.49 | +62.7% | Aug 6, 2026 |
| Piper Sandler | Analyst unavailable | $724 | $565.8 | +71.2% | Jul 13, 2026 |
| Needham | Analyst unavailable | $750 | $597.04 | +77.4% | Jul 6, 2026 |
| Piper Sandler | James Fish | $674 | $457.33 | +59.4% | Jun 15, 2026 |
| Barclays | Tim Long | $523 | $426.89 | +23.7% | May 8, 2026 |
| Morgan Stanley | Analyst unavailable | $600 | $433.82 | +41.9% | May 7, 2026 |
| Goldman Sachs | Analyst unavailable | $535 | $434.5 | +26.5% | May 7, 2026 |
| UBS | Analyst unavailable | $440 | $416.57 | +4.0% | May 7, 2026 |
| Morgan Stanley | Analyst unavailable | $675 | $391.53 | +59.6% | Apr 8, 2026 |
| Goldman Sachs | Analyst unavailable | $625 | $391.53 | +47.8% | Apr 8, 2026 |
| Robert W. Baird | Analyst unavailable | $800 | $523.63 | +89.2% | Feb 25, 2026 |
| Craig-Hallum | Jeremy Hamblin | $820 | $543.47 | +93.9% | Feb 25, 2026 |
| RBC Capital | David Paige | $735 | $543.24 | +73.8% | Feb 25, 2026 |
| Piper Sandler | James Fish | $690 | $548.22 | +63.2% | Feb 25, 2026 |
| Northcoast Research | Keith Housum | $742 | $591.16 | +75.5% | Jan 6, 2026 |
| Morgan Stanley | Meta Marshall | $713 | $555.06 | +68.6% | Dec 17, 2025 |
| RBC Capital | Analyst unavailable | $860 | $554.37 | +103.4% | Nov 17, 2025 |
| Piper Sandler | James Fish | $753 | $622.38 | +78.1% | Nov 5, 2025 |
| Raymond James | Analyst unavailable | $855 | $867.12 | +102.2% | Aug 5, 2025 |
| Northland Securities | Michael Latimore | $800 | $867.12 | +89.2% | Aug 5, 2025 |
| Needham | Joshua Reilly | $870 | $867.12 | +105.7% | Aug 5, 2025 |
| UBS | Analyst unavailable | $840 | $867.12 | +98.6% | Aug 5, 2025 |
| Craig-Hallum | Analyst unavailable | $900 | $867.12 | +112.8% | Aug 5, 2025 |
| Morgan Stanley | Meta Marshall | $885 | $729.62 | +109.3% | Jul 11, 2025 |
| Barclays | Analyst unavailable | $726 | $506.96 | +71.7% | Feb 27, 2025 |
| Morgan Stanley | Meta Marshall | $700 | $636.39 | +65.5% | Dec 3, 2024 |
| Needham | Joshua Reilly | $525 | $443.98 | +24.1% | Oct 22, 2024 |
| Goldman Sachs | Michael Ng | $441 | $443.98 | +4.3% | Oct 22, 2024 |
| Robert W. Baird | William Power | $400 | $364.39 | -5.4% | Sep 10, 2024 |
| Craig-Hallum | Jeremy Hamblin | $370 | $315.35 | -12.5% | May 7, 2024 |
| Needham | Joshua Reilly | $400 | $311.27 | -5.4% | Apr 10, 2024 |
| Argus Research | John Staszak | $380 | $306.78 | -10.1% | Mar 13, 2024 |
| Credit Suisse | Sami Badri | $300 | $225.13 | -29.1% | Apr 11, 2023 |
| Morgan Stanley | Analyst unavailable | $155 | $168.59 | -63.3% | Dec 13, 2022 |
Track every rating change on AXON the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationAxon Enterprise, Inc., founded in 1993 and headquartered in Scottsdale, Arizona, was previously known as TASER International, Inc. until its rebranding in April 2017. The company specializes in the development, production, and sale of conducted energy devices (CEDs) marketed under its well-known TASER brand, catering to both domestic and international clients. Axon's operations are divided into two primary segments: TASER, and Software and Sensors. In addition to its signature TASER devices, such as the TASER 7, X26P, X2, and consumer models, along with their corresponding cartridges, Axon offers an extensive portfolio of hardware and cloud-based software.…
Historical context
All AXON earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| DAL Delta Air Lines, Inc. | FY2026 Q3 · Calendar Q4 2026 | -2.8% | +0.0% | Delta reports strong Q3 demand while costs and capacity remain key watchpoints |
| CTAS Cintas Corporation | FY2027 Q1 · Calendar Q3 2026 | +3.0% | -3.4% | Cintas raises FY2027 guidance as Q1 growth broadens |
| PAYX Paychex, Inc. | FY2027 Q1 · Calendar Q3 2026 | +1.5% | -8.8% | Paychex maintains FY27 outlook as PEO and AI momentum strengthen |
| FPS Forgent Power Solutions, Inc. | FY2026 Q4 · Calendar Q3 2026 | +4.3% | +9.5% | Forgent Power Solutions pairs record results with an aggressive FY27 buildout |
| CPRT Copart, Inc. | FY2026 Q4 · Calendar Q3 2026 | -8.7% | -2.6% | Copart pairs international growth with ACV investment amid higher costs |
| SUNB Sunbelt Rentals Holdings Inc | FY2027 Q1 · Calendar Q3 2026 | +19.2% | +5.9% | Sunbelt raises FY27 outlook as specialty rental demand accelerates |
Latest beats and misses
Who reports nextBeat on EPS
Get the AXON recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-10T18:38:36.707185+00:00
- Polygon adjusted daily market bars · 2026-10-10T09:30:42.062475+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-10T09:30:42.059378+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-10. For educational purposes only; not investment advice.